Submitted by Nicola-Swanborough on Fri, 03/11/2017 - 15:50
People with epilepsy could benefit from new guidelines announced by the Government this week, for assessing those who receive PIP - the Personal Independence Payment benefit.
Submitted by Nicola-Swanborough on Tue, 31/10/2017 - 15:50
A standing ovation as Epilepsy Society's Professor Philip Patsalos is awarded the 2016 Excellence in Epilepsy Award by the British Chapter of the International League Against Epilepsy.
Submitted by Nicola-Swanborough on Thu, 26/10/2017 - 13:31
Our content manager, Nicola Swanborough, explains how our sodium valproate survey helped us raise awareness of risks associated with the drug in the media, parliament and with Government.
Submitted by Nicola-Swanborough on Thu, 19/10/2017 - 19:10
Although we could not see them as we watched today's sodium valproate debate via Parliament Live TV, the presence of three women -Janet Williams, Emma Murphy and Deborah Mann - as they sat in the public gallery, was very much felt in the House of Commons.
Submitted by Nicola-Swanborough on Thu, 19/10/2017 - 11:45
Epilepsy Society's chief executive, Clare Pelham, has welcomed a second letter from the Department of Health in response to her letter to health secretary Jeremy Hunt, calling for mandatory reviews for women and girls of childbearing age taking sodium valproate.
Submitted by Nicola-Swanborough on Wed, 18/10/2017 - 13:13
Arlene Foster, leader of the Democratic Unionist Party and First Minister of Northern Ireland has pledged her support for Epilepsy Society's campaign to ensure mandatory reviews for all women and girls of childbearing who take sodium valproate.
Submitted by Nicola-Swanborough on Wed, 18/10/2017 - 11:27
Sharon Ross is about to start the ketogenic diet in an attempt to control her seizures. This is the first in a series of blogs about what it involves.
Submitted by Nicola-Swanborough on Tue, 17/10/2017 - 12:26
Epilepsy Society's chief executive, Clare Pelham, receives a response from health secretry Jeremy Hunt about safety issues around epilepsy drug, sodium valproate.
Submitted by Nicola-Swanborough on Mon, 16/10/2017 - 15:11
This Thursday (19 October 2017), MPs will be meeting in the House of Commons to debate safety issues around the epilepsy drug sodium valproate.
Submitted by Nicola-Swanborough on Mon, 09/10/2017 - 13:20
Following last month's public hearing into the epilepsy drug sodium valproate, the European Medicines Agency(EMA) has now published a full summary report.